1
|
Thanusha AV, Koul V. Biocompatibility evaluation for the developed hydrogel wound dressing - ISO-10993-11 standards - in vitroand in vivostudy. Biomed Phys Eng Express 2021; 8. [PMID: 34794128 DOI: 10.1088/2057-1976/ac3b2b] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2021] [Accepted: 11/18/2021] [Indexed: 11/11/2022]
Abstract
Assessment of biocompatibility for the developed wound dressing plays a significant role in translational studies. In the present research work, a wound dressing has been developed using gelatin, hyaluronic acid and chondroitin sulfate using EDC as crosslinker in a specific manner. The characterized hydrogel wound dressing was evaluated for its biocompatibility studies by means of ISO-10993-11 medical device rules and standards. Various parameters like skin sensitization test, acute systemic toxic test, implantation study, intracutaneous reactivity test,in vitrocytotoxicity test and bacterial reverse mutation test, were evaluated and the results demonstrated its safety for the pre-clinical investigation.
Collapse
Affiliation(s)
- A V Thanusha
- Centre for Biomedical Engineering, Indian Institute of Technology Delhi, India.,Biomedical Engineering Unit, All India Institute of Medical Sciences, New Delhi, India
| | - Veena Koul
- Centre for Biomedical Engineering, Indian Institute of Technology Delhi, India.,Biomedical Engineering Unit, All India Institute of Medical Sciences, New Delhi, India
| |
Collapse
|
2
|
Khurana A, Banothu AK, Thanusha AV, Nayal A, Dinda AK, Singhal M, Bharani KK, Koul V. Preclinical efficacy study of a porous biopolymeric scaffold based on gelatin-hyaluronic acid-chondroitin sulfate in a porcine burn injury model: role of critical molecular markers (VEGFA, N-cadherin, COX-2), gamma sterilization efficacy and a comparison of healing potential to Integra™. Biomed Mater 2021; 16. [PMID: 34384056 DOI: 10.1088/1748-605x/ac1d3e] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2021] [Accepted: 08/12/2021] [Indexed: 12/24/2022]
Abstract
Development of scaffold from biopolymers can ease the requirements for donor skin autograft and plays an effective role in the treatment of burn wounds. In the current study, a porous foam based, bilayered hydrogel scaffold was developed using gelatin, hyaluronic acid and chondroitin sulfate (G-HA-CS). The fabricated scaffold was characterized physicochemically for pre- and post-sterilization efficacy by scanning electron microscopy (SEM), Fourier transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC) and thermal gravimetric analysis (TGA).In-vitrostudies proved that the scaffold promoted cellular proliferation. The efficacy of G-HA-CS scaffold was compared with Integra™ at different time points (7, 14, 21 and 42 days), in a swine second degree burn wound model. Remarkable healing potential of the scaffold was evident from the wound contraction rate, reduction of IL-6, TNF-αand C3. The expression of healing markers TGF-β1 and collagen 1 revealed significant skin regeneration with regulated fibroblast activation towards the late phase of healing (p< 0.001 at day 21 and 42 vs. control). Expression of Vascular Endothelial Growth Factor A (VEGFA), vimentin and N-cadherin were found to favor angiogenesis and skin regeneration. Mechanistically, scaffold promoted wound healing by modulation of CD-45, cyclooxygenase-2 and MMP-2. Thus, the promising results with foam based scaffold, comparable to Integra™ in swine burn injury model offer an innovative lead for clinical translation for effective management of burn wound.
Collapse
Affiliation(s)
- Amit Khurana
- Centre for Biomedical Engineering (CBME), Indian Institute of Technology (IIT) Delhi, Hauz Khas, New Delhi 110016, India.,Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science, PVNRTVU, Rajendranagar, Hyderabad 500030, Telangana, India.,Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science (CVSc), PVNRTVU, Warangal 506166, Telangana, India
| | - Anil Kumar Banothu
- Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science, PVNRTVU, Rajendranagar, Hyderabad 500030, Telangana, India.,Department of Aquatic Animal Health Management, College of Fishery Science, PVNRTVU, Pebbair, Wanaparthy 509104, Telangana, India
| | - A V Thanusha
- Centre for Biomedical Engineering (CBME), Indian Institute of Technology (IIT) Delhi, Hauz Khas, New Delhi 110016, India
| | - Aradhana Nayal
- Centre for Biomedical Engineering (CBME), Indian Institute of Technology (IIT) Delhi, Hauz Khas, New Delhi 110016, India
| | - Amit Kumar Dinda
- Department of Pathology, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi 110029, India
| | - Maneesh Singhal
- Department of Plastic, Reconstructive and Burns Surgery, J.P.N. Apex Trauma Centre, All India Institute of Medical Sciences (AIIMS), Raj Nagar, New Delhi 110029, India
| | - Kala Kumar Bharani
- Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science, PVNRTVU, Rajendranagar, Hyderabad 500030, Telangana, India.,Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science (CVSc), PVNRTVU, Warangal 506166, Telangana, India.,Department of Aquatic Animal Health Management, College of Fishery Science, PVNRTVU, Pebbair, Wanaparthy 509104, Telangana, India
| | - Veena Koul
- Centre for Biomedical Engineering (CBME), Indian Institute of Technology (IIT) Delhi, Hauz Khas, New Delhi 110016, India
| |
Collapse
|
3
|
Bhowmick S, Thanusha AV, Kumar A, Scharnweber D, Rother S, Koul V. Nanofibrous artificial skin substitute composed of mPEG–PCL grafted gelatin/hyaluronan/chondroitin sulfate/sericin for 2nd degree burn care: in vitro and in vivo study. RSC Adv 2018; 8:16420-16432. [PMID: 35540513 PMCID: PMC9080273 DOI: 10.1039/c8ra01489b] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2018] [Accepted: 04/22/2018] [Indexed: 12/26/2022] Open
Abstract
The aim of this study was to investigate the efficacy of a skin substitute composed of mPEG–PCL–grafted-gelatin (Bio-Syn)/hyaluronan/chondroitin sulfate/sericin and to study its in vitro biocompatibility with human fibroblasts, human keratinocytes and hMSCs in terms of cellular adhesion and proliferation (∼5–6 fold). mPEG–PCL was grafted into a gelatin backbone via a Michael addition reaction to prepare Bio-Syn and it was characterized using ATR-FTIR, 1H NMR and TNBS assay. Additionally, keratinocyte–hMSC contact co-culture studies showed that Bio-Syn composite scaffolds loaded with sericin promote hMSCs’ epithelial differentiation with regard to qRT-PCR gene expression (ΔNp63α and keratin 14) and expression of various epithelial markers (Pan-cytokeratin, ΔNp63α and keratin 14). In vivo efficacy studies on a 2nd degree burn wound model in Wistar rats showed an improved rate of wound contraction, histology (H&E and Van Gieson’s staining) and pro-healing marker (hexosamine, hydroxyproline, etc.) expression in granular tissue compared to using the commercial dressing Neuskin™ and a cotton gauze control. The paper demonstrates the fabrication of sericin loaded hybrid polymeric composite nanofibrous scaffold and evaluation of its cytocompatibilty in three human monocultures and biocompatibility in second degree burn wound model in Wistar rats.![]()
Collapse
Affiliation(s)
- Sirsendu Bhowmick
- Max-Bergmann Center of Biomaterials Dresden
- Technische Universität Dresden
- Dresden
- Germany
- Centre for Biomedical Engineering
| | - A. V. Thanusha
- Centre for Biomedical Engineering
- Indian Institute of Technology Delhi
- New Delhi 110016
- India
- Biomedical Engineering Unit
| | - Arun Kumar
- Centre for Biomedical Engineering
- Indian Institute of Technology Delhi
- New Delhi 110016
- India
- Biomedical Engineering Unit
| | - Dieter Scharnweber
- Max-Bergmann Center of Biomaterials Dresden
- Technische Universität Dresden
- Dresden
- Germany
| | - Sandra Rother
- Max-Bergmann Center of Biomaterials Dresden
- Technische Universität Dresden
- Dresden
- Germany
| | - Veena Koul
- Centre for Biomedical Engineering
- Indian Institute of Technology Delhi
- New Delhi 110016
- India
- Biomedical Engineering Unit
| |
Collapse
|